Patent Application
App. No. 14/555,993
ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
Loading inventors, assignments & file history…
Abstract
The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
Claims (2)
1 - 24 . (canceled)
25 . A method of treating cystinosis comprising administering a cysteamine composition twice per day.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 19, 2015
From: DOHIL, RANJAN; SCHNEIDER, JERRY
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 036365/0172 →